BSFAF (BSF Enterprise) EBITDA Margin %: -1,162.79% (As of Sep. 2025)


What is BSF Enterprise EBITDA Margin %?

BSF Enterprise BSFAF EBITDA Margin % is -1,162.79% as of Sep. 2025. The stock has 3 warning signs investors should review. Among 944 Biotechnology companies, BSF Enterprise ranks worse than 84.85% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BSF Enterprise's EBITDA for the six months ended in Sep. 2025 was $-0.50 Mil. BSF Enterprise's Revenue for the six months ended in Sep. 2025 was $0.04 Mil. Therefore, BSF Enterprise's EBITDA margin for the quarter that ended in Sep. 2025 was -1,162.79%.

BSF Enterprise  (OTCPK:BSFAF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

BSF Enterprise EBITDA Margin % Related Terms

BSF Enterprise EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for BSF Enterprise's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BSF Enterprise EBITDA Margin % Chart

BSF Enterprise Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 -11,300.00 -2,885.71 -2,073.61

BSF Enterprise Semi-Annual Data
Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,731.25 -1,482.61 -23,120.00 -3,522.22 -1,162.79

BSFAF vs VRTX, REGN, ALNY: EBITDA Margin % Comparison

For the Biotechnology subindustry, BSF Enterprise's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BSF Enterprise EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BSF Enterprise's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BSF Enterprise's EBITDA Margin % falls into.


BSF Enterprise EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BSF Enterprise's EBITDA Margin % for the fiscal year that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=-1.493/0.072
=-2,073.61 %

BSF Enterprise's EBITDA Margin % for the quarter that ended in Sep. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-0.5/0.043
=-1,162.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -1,162.79% mean?
BSF Enterprise (BSFAF) has a EBITDA Margin % of -1,162.79% as of Sep. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BSF Enterprise and its competitors. According to the industry distribution chart, BSF Enterprise ranks #801 out of 944 companies in the Biotechnology industry, placing it in the top 84.9%.
Is BSF Enterprise's EBITDA Margin % too high?
BSF Enterprise's current EBITDA Margin % is -1,162.79%. Based on the distribution chart, BSF Enterprise ranks #801 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BSF Enterprise's EBITDA Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BSF Enterprise ranks #801 out of 944 companies for EBITDA Margin %. This places BSF Enterprise in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Biotechnology company?
A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BSF Enterprise and its competitors. BSF Enterprise's current EBITDA Margin % is -1,162.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current EBITDA Margin % of -1,162.79%. The current EBITDA Margin % is -1,162.79%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current EBITDA Margin % is -1,162.79% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BSF Enterprise Business Description

Other Exchanges BSFA:UK
Address 2 Portman Street, London, GBR, W1H 6DU
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.